Ray Dalio Nevro Corp Transaction History

Bridgewater Associates, LP

  • $17.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$13.56 - $20.78 $66,538 - $101,967
-4,907 Reduced 12.97%
32,926 $475,000
Q4 2023

Feb 14, 2024
SELL
$14.18 - $22.31 $62,874 - $98,922
-4,434 Reduced 10.49%
37,833 $814,000
Q3 2023

Nov 13, 2023
BUY
$18.22 - $25.85 $72,807 - $103,296
3,996 Added 10.44%
42,267 $812,000
Q2 2023

Aug 11, 2023
SELL
$22.62 - $39.32 $95,682 - $166,323
-4,230 Reduced 9.95%
38,271 $972,000
Q1 2023

May 12, 2023
BUY
$30.17 - $41.11 $47,246 - $64,378
1,566 Added 3.83%
42,501 $1.54 Million
Q4 2022

Feb 13, 2023
SELL
$36.43 - $49.4 $509,291 - $690,612
-13,980 Reduced 25.46%
40,935 $1.62 Million
Q3 2022

Nov 10, 2022
BUY
$40.66 - $53.03 $4,269 - $5,568
105 Added 0.19%
54,915 $2.56 Million
Q2 2022

Aug 11, 2022
BUY
$40.85 - $77.67 $248,163 - $471,845
6,075 Added 12.47%
54,810 $2.4 Million
Q1 2022

May 13, 2022
BUY
$59.95 - $92.06 $697,997 - $1.07 Million
11,643 Added 31.39%
48,735 $3.53 Million
Q4 2021

Feb 14, 2022
BUY
$81.07 - $121.29 $385,731 - $577,097
4,758 Added 14.72%
37,092 $3.01 Million
Q3 2021

Nov 12, 2021
SELL
$101.99 - $166.36 $248,753 - $405,752
-2,439 Reduced 7.01%
32,334 $3.76 Million
Q2 2021

Aug 13, 2021
BUY
$141.6 - $179.06 $4.92 Million - $6.23 Million
34,773 New
34,773 $5.77 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email